Although COVID-19 has faded from the headlines, SARS-CoV-2—the coronavirus behind the pandemic—is still rampantly infecting people around the world. Public health officials fear as the virus continues to evolve, it will ...
Mar 13, 2024
0
53
Researchers from the UoC's Center for Biochemistry at the Faculty of Medicine and the UoC CECAD Cluster of Excellence in Aging Research have discovered that an excessive immune response can be prevented by the intramembrane ...
Mar 7, 2024
0
19
Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 ...
Mar 29, 2023
0
233
Developing new drugs that remain potent against emerging variants of COVID-19 is essential to stopping the spread of the highly contagious disease and protecting human health.
May 2, 2022
0
41
The Biden administration announced this week that it will take new measures to expand access to Paxlovid, the first medication developed to treat COVID-19. The White House plans to nearly double the number of places that ...
May 2, 2022
0
3
The Biden administration announced plans on April 26, 2022, to increase the availability of the COVID-19 drug Paxlovid, vowing to get more of the treatment pills into the hands of Americans.
Apr 29, 2022
0
10
The transgender population encounters numerous barriers to receiving proper medical care. Even when treatment is accessible, healthcare providers may lack comprehensive knowledge on how to treat them either due to insufficient ...
Apr 26, 2022
0
4
University of Oxford researchers assessed evidence from 34 studies, involving more than 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of ...
Apr 12, 2022
0
30
A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin prevented cells to be infected ...
Apr 11, 2022
0
8
Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
